Client of a consultant lobbyist
Stem Cell Network
- Meetings this Parliament
- 5
- With MPs
- 4
- Since Nov 2021
- 5
- Active registrations
- 1
Most recent reported meeting: Sep 17, 2026.
Lobbying by Stem Cell Network: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Jul 20, 2026 Receives government funding
Consultant Ujwal Ganguly of Temple Scott Associates Inc.
Consultant lobbyists
- Ujwal Ganguly
Institutions they may lobby: Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada
What they're lobbying on (1)Hide details
- Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
Registration 945250-387245-1. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Ujwal Ganguly · Consultant
- Guillaume Deschênes-Thériault · Member of Parliament
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Ujwal Ganguly · Consultant
- Jennifer McKelvie · Member of Parliament
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Ujwal Ganguly · Consultant
- Sean Casey · Member of Parliament
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Ujwal Ganguly · Consultant
- Fares Al Soud · Member of Parliament
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
-
Reported by Ujwal Ganguly · Consultant
- Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
Seek federal funding through the budget process to support the development, commercialization and manufacturing scale-up of advanced therapeutics in Canada.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.